Citigroup Inc Moderna, Inc. Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Citigroup Inc holds 453,532 shares of MRNA stock, worth $29.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

453,532

Previous 428,197 5.92%

Holding current value

$29.8 Million

Previous $45.6 Million 18.03%

% of portfolio

0.04%

Previous 0.03%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$101.21 - $166.61 $2.56 Million - $4.22 Million	25,335 Added 5.92%	453,532 $53.9 Million
Q1 2024 May 10, 2024	SELL	$85.37 - $115.44 $6.34 Million - $8.57 Million	-74,273 Reduced 14.78%	428,197 $45.6 Million
Q4 2023 Feb 09, 2024	SELL	$69.51 - $104.43 $12.3 Million - $18.5 Million	-176,908 Reduced 26.04%	502,470 $50 Million
Q3 2023 Nov 09, 2023	BUY	$96.41 - $126.61 $8.37 Million - $11 Million	86,811 Added 14.65%	679,378 $70.2 Million
Q2 2023 Aug 10, 2023	SELL	$118.5 - $160.53 $13.5 Million - $18.2 Million	-113,607 Reduced 16.09%	592,567 $72 Million
Q1 2023 May 11, 2023	SELL	$135.66 - $197.02 $51.5 Million - $74.9 Million	-379,989 Reduced 34.98%	706,174 $108 Million
Q4 2022 Feb 09, 2023	BUY	$118.38 - $210.04 $34.8 Million - $61.8 Million	294,199 Added 37.15%	1,086,163 $195 Million
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $16.7 Million - $27.5 Million	-141,474 Reduced 15.16%	791,964 $93.7 Million
Q2 2022 Aug 10, 2022	SELL	$117.13 - $176.59 $14.7 Million - $22.1 Million	-125,245 Reduced 11.83%	933,438 $133 Million
Q1 2022 May 12, 2022	SELL	$126.46 - $235.05 $5.39 Million - $10 Million	-42,605 Reduced 3.87%	1,058,683 $182 Million
Q4 2021 Feb 10, 2022	BUY	$225.82 - $368.51 $124 Million - $203 Million	550,315 Added 99.88%	1,101,288 $280 Million
Q3 2021 Nov 10, 2021	BUY	$221.9 - $484.47 $122 Million - $267 Million	550,973 New	550,973 $212 Million

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account